US2008171725A1PendingUtilityA1

Methods, Compositions and Articles of Manufacture for Enhancing Survivability of Cells, Tissues, Organs, and Organisms

Individually held — no corporate assignee on recordPriority: Apr 20, 2005Filed: Aug 10, 2007Published: Jul 17, 2008
Est. expiryApr 20, 2025(expired)· nominal 20-yr term from priority
A61P 7/04A61P 7/06A61P 9/10A61P 7/00A61P 43/00A61P 9/00A61P 41/00A61P 17/02A61K 31/165A61K 45/06A61K 31/185A61K 33/04A61K 31/26A61K 31/275A61K 31/21A61K 31/095A61K 31/555A61K 31/66A01N 1/126A01N 1/10
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.

Claims

exact text as granted — not AI-modified
1 . A method for enhancing survivability of biological matter comprising providing to the biological matter an effective amount of at least one active compound. 
     
     
         2 . The method of  claim 1 , wherein the active compound is an oxygen antagonist. 
     
     
         3 . The method of  claim 1 , wherein the matter is exposed to the active compound. 
     
     
         4 . The method of  claim 1 , wherein the active compound is a chalcogenide. 
     
     
         5 . The method of  claim 1 , wherein the active compound has a chemical structure of Formula I or Formula IV. 
     
     
         6 . The method of  claim 5 , wherein the matter is exposed to a precursor of a chemical structure of Formula I or Formula IV. 
     
     
         7 . The method of  claim 1 , wherein the matter is provided with a combination of active compounds. 
     
     
         8 . The method of  claim 1 , wherein the matter is provided with the active compound before, during, or after an injury, the onset or progression of a disease, or hemorrhaging in the matter. 
     
     
         9 . The method of  claim 8 , wherein the injury involves hemorrhaging. 
     
     
         10 . The method of  claim 9 , wherein the injury is from an external physical source. 
     
     
         11 . The method of  claim 8 , wherein the active compound is provided before the injury or before the onset or progression of the disease. 
     
     
         12 . The method of  claim 8 , wherein the injury or disease is associated with a reduction in metabolism or temperature of the matter. 
     
     
         13 . The method of  claim 12 , wherein the injury is a surgery. 
     
     
         14 .- 149 . (canceled)

Join the waitlist — get patent alerts

Track US2008171725A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.